152 related articles for article (PubMed ID: 11251978)
21. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB
Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035
[TBL] [Abstract][Full Text] [Related]
22. Lack of bystander killing in herpes simplex virus thymidine kinase-transduced colon cell lines due to deficient connexin43 gap junction formation.
McMasters RA; Saylors RL; Jones KE; Hendrix ME; Moyer MP; Drake RR
Hum Gene Ther; 1998 Oct; 9(15):2253-61. PubMed ID: 9794209
[TBL] [Abstract][Full Text] [Related]
23. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
[TBL] [Abstract][Full Text] [Related]
24. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer.
Chen W; Yan C; Hou J; Pu J; Ouyang J; Wen D
Urol Oncol; 2008; 26(4):397-405. PubMed ID: 18367126
[TBL] [Abstract][Full Text] [Related]
25. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
26. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy.
Estin D; Li M; Spray D; Wu JK
Neurosurgery; 1999 Feb; 44(2):361-8; discussion 368-9. PubMed ID: 9932890
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
[TBL] [Abstract][Full Text] [Related]
28. Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system.
Bai S; Du L; Liu W; Whittle IR; He L
Biochem Biophys Res Commun; 1999 Jun; 259(2):455-9. PubMed ID: 10362529
[TBL] [Abstract][Full Text] [Related]
29. Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.
Luo C; Mori I; Goshima F; Ushijima Y; Nawa A; Kimura H; Nishiyama Y
J Gene Med; 2007 Oct; 9(10):875-83. PubMed ID: 17685493
[TBL] [Abstract][Full Text] [Related]
30. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
31. [The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy].
Zhang L; Liu T; Cui Q; Gao J
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):440-4. PubMed ID: 11869559
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of resveratrol and HSV-TK/GCV therapy on murine hepatoma cells.
Xiao J; Wang X; Wu Y; Zhao Q; Liu X; Zhang G; Zhao Z; Ning Y; Wang K; Tan Y; Du B
Cancer Biol Ther; 2019; 20(2):183-191. PubMed ID: 30257140
[TBL] [Abstract][Full Text] [Related]
33. [All-trans retinoic acid augments the bystander effect of herpes simplex virus thymidine kinase/ganciclovir system in the treatment of tongue carcinoma cell line].
Wang AX; Huang HZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):24-6. PubMed ID: 12760771
[TBL] [Abstract][Full Text] [Related]
34. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
Marconi P; Tamura M; Moriuchi S; Krisky DM; Niranjan A; Goins WF; Cohen JB; Glorioso JC
Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
[TBL] [Abstract][Full Text] [Related]
35. Influence of p53 status on the HSV-Tk/GCV-induced bystander effect in a panel of human ovarian carcinoma cell lines.
van Dillen IJ; Mulder NH; Sluiter WJ; Meijer C; de Jong S; Loncarek J; Mesnil M; de Vries EF; Vaalburg W; Hospers GA
Oncol Res; 2005; 15(3):151-9. PubMed ID: 16050136
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells.
Rubsam LZ; Boucher PD; Murphy PJ; KuKuruga M; Shewach DS
Cancer Res; 1999 Feb; 59(3):669-75. PubMed ID: 9973216
[TBL] [Abstract][Full Text] [Related]
37. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
[TBL] [Abstract][Full Text] [Related]
38. Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines.
Imaizumi K; Hasegawa Y; Kawabe T; Emi N; Saito H; Naruse K; Shimokata K
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):205-12. PubMed ID: 9476907
[TBL] [Abstract][Full Text] [Related]
39. Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery.
Tanaka M; Fraizer GC; De La Cerda J; Cristiano RJ; Liebert M; Grossman HB
Gene Ther; 2001 Jan; 8(2):139-48. PubMed ID: 11313783
[TBL] [Abstract][Full Text] [Related]
40. Connexin 43-mediated bystander effect in two rat glioma cell models.
Sanson M; Marcaud V; Robin E; Valéry C; Sturtz F; Zalc B
Cancer Gene Ther; 2002 Feb; 9(2):149-55. PubMed ID: 11857032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
